CAM
IOVA icon

Cresset Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Cresset Asset Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Hold
383,786
– – 0.01% 736
2026
Q1 		$1.35M Sell
383,786
-74,000
-16% -$237K 0.01% 676
2025
Q4 		$1.25M Buy
457,786
+267,300
+140% +$618K 0.01% 714
2025
Q3 		$413K Buy
190,486
+213
+0.1% +$503 ﹤0.01% 1109
2025
Q2 		$327K Buy
190,273
+112,000
+143% +$279K ﹤0.01% 1102
2025
Q1 		$261K Sell
78,273
-29
-0% -$150 ﹤0.01% 1396
2024
Q4 		$579K Sell
78,302
-2,507
-3% -$23.2K ﹤0.01% 1016
2024
Q3 		$759K Buy
80,809
+866
+1% +$8.21K ﹤0.01% 1300
2024
Q2 		$641K Buy
79,943
+8,917
+13% +$95.6K ﹤0.01% 1324
2024
Q1 		$1.05M Sell
71,026
-5,714
-7% -$66.5K 0.01% 951
2023
Q4 		$624K Buy
76,740
+31,172
+68% +$163K ﹤0.01% 1109
2023
Q3 		$207K Buy
45,568
+13,276
+41% +$86.7K ﹤0.01% 1609
2023
Q2 		$227K Buy
32,292
+1,292
+4% +$9.25K ﹤0.01% 1672
2023
Q1 		$189K Hold
31,000
– – ﹤0.01% 749
2022
Q4 		$198K Sell
31,000
-14,000
-31% -$109K ﹤0.01% 638
2022
Q3 		$431K Buy
45,000
+20,968
+87% +$242K 0.01% 557
2022
Q2 		$265K Sell
24,032
-4,762
-17% -$62.4K ﹤0.01% 747
2022
Q1 		$479K Buy
28,794
+9,407
+49% +$145K 0.01% 619
2021
Q4 		$369K Buy
19,387
+495
+3% +$10.9K ﹤0.01% 802
2021
Q3 		$466K Sell
18,892
-4,174
-18% -$98.4K 0.01% 650
2021
Q2 		$600K Buy
23,066
+12,531
+119% +$326K 0.01% 504
2021
Q1 		$333K Buy
+10,535
New +$437K 0.01% 628

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Cresset Asset Management's IOVA Position: Q2 2026 in Review

Cresset Asset Management held its Iovance Biotherapeutics (IOVA) position steady in Q2 2026 at 383,786 shares worth $1.6M. The position accounts for 0.01% of the portfolio, ranked #736.

Cresset Asset Management first reported a position in IOVA in Q1 2021 and has held it in 22 quarters since. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Cresset Asset Management held 383,786 shares of Iovance Biotherapeutics worth $1.6M as of Q2 2026.
  • Cresset Asset Management left its Iovance Biotherapeutics share count unchanged in Q2 2026.
  • Iovance Biotherapeutics made up 0.01% of Cresset Asset Management's portfolio in Q2 2026, its #736 holding.
  • Cresset Asset Management first reported a position in Iovance Biotherapeutics in Q1 2021 and has held it in 22 quarters since.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.